MedTrace Logo

Prognostic Indicators of Gullian-Barre Syndrome

NCT06300359 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-03-15

No results posted yet for this study

Summary

Prognostic indicators of Gullian-Barre syndrome and the predictive factors associated with worse prognosis in the Guillain-Barré syndrome (GBS), which can be helpful to fully evaluate the disease progression and provide proper treatments.

Conditions

  • Guillain-Barre Syndrome

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Amira A Sayed Amin, Resident · Assiut University

  • Gamal A Abdelaal Asker, Professor · Assiut University

  • Azhar A Mohammed Mohammed, Lecturer · Assiut University

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-31
Primary Completion
2025-04-30
Completion
2025-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06300359 on ClinicalTrials.gov